TDM3000-MS
Intelligent two-dimensional liquid chromatography mass spectrometer (2D-LC-MS), designed for therapeutic drug monitoring (TDM) in blood samples.
- Two-dimensional liquid separation (2D-LC) coupled with MS
- Dedicated to therapeutic drug monitoring (TDM)
- Qualitative and quantitative determination of small organic molecules in blood
- Simple sample preparation, up to 150 samples per run
- High automation in a compact build
- Performance meeting national metrological requirements
The TDM3000-MS is a Skyray-developed two-dimensional liquid chromatography mass spectrometer (2D-LC-MS). The instrument separates target substances using two-dimensional liquid chromatography and then determines their content by mass spectrometry. In clinical use it qualitatively and quantitatively determines small organic molecules in blood samples — both diagnostic markers (endogenous substances: amino acids, vitamins, hormones) and therapy-monitoring compounds (exogenous substances: therapeutic and toxic drugs). The product is designed specifically for therapeutic drug monitoring (TDM): it overcomes the bottleneck of value traceability and standardization in clinical use and solves the typical problems of conventional LC-MS systems — low automation, complexity and high investment. All parameters meet national metrological requirements.
Applications
- Therapeutic drug monitoring (TDM)
- Determination of amino acids, vitamins and hormones in blood
- Monitoring of therapeutic and toxic drugs
- Clinical and diagnostic laboratories
What to ask about
Two-dimensional liquid separation improves selectivity in the complex blood matrix, while a compact, automated build simplifies bringing the method into routine laboratory use. Contact us to discuss the range of target compounds and configuration.
The full technical specification and configuration will be provided in the datasheet PDF.
Datasheet (PDF) — coming soon